Frailty and Intraoperative Hypoxemia Risk in Elderly ERCP Patients

ConditionHypoxemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorChina-Japan Friendship Hospital

About this trial

Intraoperative hypoxemia is a common and serious complication during monitored anesthesia care for elective endoscopic retrograde cholangiopancreatography (ERCP), especially in older adults. Frail patients have reduced physiologic reserve and are at increased risk of life-threatening events including unplanned intubation, hemodynamic collapse, and hypoxic brain injury. However, the independent relationship between frailty and intraoperative hypoxemia during sedated ERCP remains poorly defined, and no validated risk prediction model exists for this high-risk population. This single-center, dual-cohort study will be conducted at China-Japan Friendship Hospital to evaluate whether preoperative frailty can predict intraoperative hypoxemia in patients aged 65 years and older undergoing elective ERCP. Frailty will be assessed primarily using the Frailty Index (FI), with secondary screening by the Modified Frailty Index-11 (mFI-11), Edmonton Frail Scale (EFS), Clinical Frailty Scale (CFS), FRAIL scale, and Fried phenotype. The primary outcome is intraoperative hypoxemia, defined as SpO₂ \< 90% for 5 seconds or longer. In the retrospective phase (n = 313), investigators will identify risk factors and develop a preliminary prediction model. In the prospective phase (n = 388), the model will be validated, refined, and internally tested for discrimination, calibration, and clinical utility. This study aims to establish frailty as a reliable preoperative risk marker and provide a clinically practical prediction tool to support risk stratification, personalized sedation strategies, and perioperative safety in elderly patients undergoing ERCP.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 65 years or older

Elective endoscopic retrograde cholangiopancreatography (ERCP) under anesthesia sedation

American Society of Anesthesiologists (ASA) physical status II-IV

Expected procedure duration less than 60 minutes

Disqualifiers

Emergency ERCP

Severe anemia (hemoglobin < 60 g/L) or conditions interfering with accurate 3. SpO₂ measurement

Trial population

This observational cohort study will enroll elderly patients aged 65 years and older who are scheduled for elective endoscopic retrograde cholangiopancreatography (ERCP) under anesthesia sedation at China-Japan Friendship Hospital. The study population consists of two sequential cohorts: a retrospective cohort of 313 patients with complete electronic health record data and a prospective cohort of 388 patients to be recruited prospectively. Eligible participants include those with American Society of Anesthesiologists (ASA) physical status II-IV and an expected procedure duration of less than 60 minutes, with adequate intraoperative pulse oximetry monitoring.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

701 Participants
are grouped into 1 trial group
Group A: Frailty-Hypoxemia ERCP Cohort

Trial outcomes

Primary outcomes

1

Intraoperative hypoxemia

Intraoperative hypoxemia defined as pulse oxygen saturation (SpO₂) \< 90% lasting 5 seconds or longer during the procedure.

Time frame
Intraoperatively

Secondary outcomes

1

Severe intraoperative hypoxemia

Severe hypoxemia defined as SpO₂ \< 90% for more than 1 minute, or SpO₂ \< 75%.

Time frame
Intraoperatively
2

Postoperative hypoxemia

Hypoxemia on admission to the ward, defined as SpO₂ \< 90% on room air.

Time frame
Within 2 hours after completion of ERCP
3

Intraoperative hemodynamic instability

Clinically significant hypotension, hypertension, or arrhythmia requiring intervention.

Time frame
Intraoperatively
4

Serious anesthesia-related adverse events

Aspiration, circulatory instability, unplanned endotracheal intubation, hypoxic encephalopathy, or death.

Time frame
up to 1 month

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: